Before the Open (Aug 13)

Posted on by Jason Leavitt

Good morning. Happy Monday. Hope you had a good weekend.
The Asian/Pacific markets suffered relatively big losses. Japan, Hong Kong, South Korea, Taiwan, Indonesia and the Philippines were all very weak. Europe, Africa and the Middle East are currently mostly down. Turkey is down more than 4%; the UAE, Greece, Hungary, Portugal, Austria and Saudi Arabia are also weak. South Africa is doing well. Futures in the States were down a bunch overnight but are now pointing to a flat open for the cash market.
—————
ChartBook: List of ETFs
—————
The dollar is flat. Oil and copper are down. Gold and silver are down. Bonds are down.
Overnight Stock Movers from barchart.com…
Planet Fitness (PLNT +6.46%) was downgraded to ‘Neutral’ from ‘Overweight’ at JPMorgan Chase with a price target of $50.
Bank OZK (OZK -0.17%) was downgraded to ‘Underweight’ from ‘Overweight’ at Barclays with a price target of $38.
AGCO (AGCO -3.25%) was downgraded to ‘Underweight’ from ‘Neutral at JPMorgan Chase with a price target of $55.
Dollar Tree (DLTR -0.29%) was upgraded to ‘Overweight’ from ‘Neutral’ at Atlantic Equities LLP with a price target of $110.
Papa John’s (PZZA -2.87%) was upgraded to ‘Buy’ from ‘Neutral’ at Longbow Research with a price target of $52.
Mylan NV (MYL +1.64%) was upgraded to ‘Outperform’ from ‘Sector Perform’ at RBC Capital Markets with a price target of $51.
Third Point Off Shore Investors Ltd announced that it had acquired a 3.1% stake in NXP Semiconductors NV (NXPI -1.17%) at the end of Q2.
Establishment Lab Holdings (ESTA +2.63%) was rated a new ‘Buy’ at Jeffries with a price target of %35.
Aramark (ARMK +2.01%) was rated a new ‘Outperform’ at Credit Suisse with a price target of $52.
Energen (EGN +0.03%) may move higher initially this morning after Icahn Associates acquired an additional 657,077 shares in Energen from Aug 8-10 and raised its stake in the company to 6.72 million shares, making it the fifth largest shareholder in the company.
Amicus Therapeutics (FOLD +1.59%) rose 2% in after-hours trading after the company won FDA approval for its Galafold drug to treat Fabry disease.
ADT (ADT +5.08%) was rated a new ‘Outperform’ at Credit Suisse with a price target of $12.50.
Today’s Economic Calendar
none
Other…
today’s upgrades/downgrades from briefing.com
this week’s Earnings from Morningstar
this week’s Economic Numbers/Reports powered by ECONODAY

One thought on “Before the Open (Aug 13)”

  1. Americans are buying much with credit cards, the most profitable form of lending for banks, where interest rates can exceed 30%, though the average cost of funding for banks is still below 1%. This is a deal made in heaven for banks – until consumers collapse under this high-interest debt. Oct is likely the cycle top this fall. Have a care.

Leave a Reply